Oticon Reveal Hearing Aids: Dual AI, Availability, and Who It's For

Oticon announced Reveal on August 12, 2026, positioning it as the world's first hearing aid powered by a Dual AI system. The company says it combines two dedicated AI systems, one for speech and one for context, to deliver clearer speech and meaningful surrounding sounds in real time. It became orderable starting August 24, 2026.

The direct answer: what Reveal is and when it became available

Oticon Reveal is a prescription hearing aid family built on a new platform Oticon calls Reveal AI. It introduces what the company describes as a Dual AI system: two dedicated AI systems working simultaneously, one for speech (Speech AI) and one for contextual sounds (Context AI). Oticon's positioning statement is that this architecture delivers speech clarity and meaningful environmental sounds in optimal balance, across all listening environments, all day.

Oticon Inc. announced Reveal in a U.S. press release dated August 12, 2026 (Somerset, NJ). The company stated Reveal would be available to order starting August 24, 2026. That date is the professional ordering date for hearing care providers, not a consumer retail launch date. Availability through individual clinics varies by market, inventory, and provider network.

Reveal is a prescription medical device. It is fitted by a licensed audiologist or hearing aid dispenser to your audiogram, with real-ear verification and ongoing clinical care. It is not an over-the-counter device, and it is not self-fitting software like the earbud hearing aid features discussed in our earbuds guide.

What Dual AI actually is, in plain English

The term "Dual AI" as Oticon uses it means two separate AI systems running at the same time on the same chip.

The Speech AI continuously identifies and enhances speech from people around the user. Oticon's positioning is that it provides "crystal-clear speech" and the company claims it delivers "industry-leading access to speech" (internal research brief, Denker 2026).

The Context AI recognizes and balances surrounding contextual sounds. Oticon's stated goal is to preserve meaningful environmental sounds rather than suppress them with aggressive noise reduction. The company cites emerging BrainHearing research suggesting the brain needs both clear speech and preserved contextual sound to create optimal understanding.

Both AI systems run on what Oticon calls the Reveal AI platform. The company says the systems work together in real time, adapting continuously throughout the day as the user moves through different listening environments. Oticon describes this as "always-on, all-day support" across all environments.

This is a different approach from what Oticon characterizes as the industry trend toward aggressive AI noise reduction that prioritizes speech at the expense of other sounds. Oticon's argument is that a "speech-only" AI approach conflicts with how the brain naturally processes auditory input. The company says optimal understanding happens at a natural balance point where speech is clear and relevant context is preserved.

Importantly, "Dual AI" is Oticon's product positioning term. It does not refer to a regulatory classification or an industry-standard performance metric. Other manufacturers use AI for different purposes in their platforms. Comparing "Dual AI" to other platforms requires looking at clinical outcomes in head-to-head studies, not at marketing terms.

Manufacturer claims, and what they actually mean

Oticon's press materials for Reveal include several specific performance numbers. These numbers come from internal Oticon research briefs, not from independent peer-reviewed studies or third-party verification. Treat them as manufacturer claims, not verified rankings.

60% stronger brain response

Oticon states that Reveal delivers a "60% stronger brain response" compared to prior approaches. The citation is Zapata-Rodriguez et al. (2026), described as an Oticon Research Brief titled "Oticon Reveal: Supporting the brain with an improved neural code."

This is an internal company research brief, not a published journal article. The claim is about neural response, measured in a way the public summary does not detail. It is not a claim about speech understanding scores, user satisfaction, or real-world outcomes. It is a neurophysiological measurement.

Up to 25 dB more gain than top competitors

Oticon claims that Reveal Optimizer (the feedback-prevention system in Reveal) provides "up to 25 dB more gain than top competitors." The citation is Denker (2026), an Oticon Research Brief titled "Reveal Optimizer: Technical evidence." The Hearing Review launch writeup states this comparison is against the "top 3 competitors," per manufacturer claim.

This is a claim about feedback headroom, not about audibility or speech understanding. The "up to" qualifier means the 25 dB figure is a maximum observed in specific test conditions, not a typical result. The comparison is internal: Oticon chose the competitors, the test method, and the reporting format. It has not been independently replicated.

30% faster feedback prevention, 4x precision

The company reports that Reveal Optimizer delivers 30% faster feedback prevention and four times greater precision compared to Oticon's own previous systems. These numbers are also from the Denker (2026) research brief, and they are manufacturer-reported technical specifications.

Faster and more precise feedback prevention means more stable fittings and more usable gain before the hearing aid starts whistling. That matters for fitting difficult losses. The numbers are not verified by an independent lab.

Connectivity features, in plain English

Oticon Reveal introduces a new connectivity platform. The company describes it as offering enhanced signal strength for improved stability and range while streaming, enabling hands-free calls and audio streaming with greater freedom of movement.

iPhone, iPad, Apple Watch

Reveal is a Made for iPhone device, meaning it can connect directly to an iPhone, iPad, or Apple Watch without an intermediary streamer. Hands-free calls and audio streaming work natively.

Android

Oticon describes Reveal as "optimized for Android." The press materials do not specify Android Audio Streaming for Hearing Aids (ASHA) protocol support or direct Android connectivity details. Confirm compatibility with your specific Android device and OS version with your hearing care provider.

Bluetooth LE Audio and Auracast

Reveal supports Bluetooth LE Audio, the updated Bluetooth standard designed for lower power consumption and improved audio quality. It also supports Auracast broadcast audio, a feature that allows users to receive audio broadcasts in public spaces.

What that means in practice: users can hear public announcements more clearly in venues that broadcast via Auracast (airports, theaters, gyms, museums), follow audio in shared spaces, or share audio streams with others nearby. Auracast availability depends on the venue. It is not a replacement for traditional hearing loops.

How Reveal sits in Oticon's current portfolio

Oticon has been actively launching products throughout 2026. Reveal is the newest platform-level introduction, but it joins a portfolio that already includes Intent, Zeal, and Verit, all announced or expanded in 2026. Here is how they fit together.

Oticon Intent: the 4D Sensor flagship

Oticon Intent runs on the Sirius platform and anchors Oticon's current rechargeable receiver-in-canal (RIC) lineup. Intent is built around 4D Sensor technology, which Oticon describes as sensors that track head and body movement to adapt sound processing to the user's intent. It is sold in four technology levels (Intent 1 through 4, where 1 is premium). Intent is well-documented, widely available, and the model most clinicians are familiar with.

Oticon Zeal: discreet rechargeable in-the-ear

Oticon Zeal was announced January 26, 2026 for the U.S. market. It is also on the Sirius platform. Zeal is a discreet rechargeable in-the-ear (ITE) style, marketed as Oticon's most discreet rechargeable hearing aid. It is sold in four levels (Zeal 1 through 4). Zeal brought rechargeable batteries to an in-the-ear form factor, which historically required disposable zinc-air cells.

Oticon Verit: premium zinc-air family

Oticon Verit launched April 14, 2026 as a premium family built around disposable zinc-air batteries. It is positioned for people who prefer not to deal with a charger. Verit is available in three styles. It is also on the Sirius platform. Oticon's public material does not clearly set out the technology-level range for Verit.

Where Reveal fits

Reveal is built on a new platform (Reveal AI), not the Sirius platform that Intent, Zeal, and Verit share. That means Reveal is not an incremental update to Intent or a new style in the Intent family. It is a distinct product line.

As of August 25, 2026, Oticon has not published a clear style matrix, technology-level range, or fitting-range chart for Reveal in consumer-facing materials. The Hearing Review launch article's featured image caption mentions "miniRITE AI," but that single photo caption is not enough to conclude Reveal is only available in one style. Professional datasheets may include more detail.

The catalog page for Oticon Reveal notes that public material is thin and that style matrix, battery type, and level range are not clearly published yet. If a clinician quotes you a specific Reveal model, ask for the current Oticon datasheet to confirm the specification.

Which one is "best" depends entirely on your hearing loss, your listening environments, your dexterity, whether you want a rechargeable or disposable battery, and which style fits your ear. A licensed audiologist can help you choose. Browse the full catalog at hearingaidfinder.org/hearing-aids.

Who Reveal is a reasonable next step for

Oticon Reveal is a prescription hearing aid. It is fitted by a licensed professional to your audiogram, with real-ear verification and ongoing care. If you are considering Reveal, most of these should describe you:

• You have a documented hearing loss that requires professional fitting. You have had a hearing test conducted by an audiologist, and your audiogram shows a loss that falls within Reveal's fitting range (which Oticon has not publicly published as of August 25, 2026).
• You are looking for a current-generation Oticon device and your clinician has recommended Reveal as a candidate based on your loss and your listening needs.
• You value access to both clear speech and contextual environmental sounds, and Oticon's BrainHearing approach aligns with how you want your hearing aids to process sound.
• You want Bluetooth connectivity for hands-free calls, audio streaming, and future access to Auracast-enabled public venues.
• You are willing to pay for a prescription device. As discussed in our cost guide, private-pay prescription pairs commonly run $1,400 to $7,000, averaging about $3,400. That price includes the device, testing, fitting, verification, follow-up care, and warranty.
• You are comfortable with the fact that Reveal is very new and that long-term user reviews, independent clinical studies, and real-world outcome data are not yet available.

When to wait, or see a clinician first

Reveal is not the right choice if any of these describe you:

1. You have not had a hearing test in the past year, or ever. Get an audiogram first. It confirms your loss is within the fitting range for any device you are considering, and it rules out treatable causes such as impacted wax or middle ear fluid.
2. You have sudden or rapidly worsening hearing loss. Sudden sensorineural hearing loss is a medical emergency. Amplification is not the first step. See a physician or audiologist immediately.
3. Your hearing loss is in only one ear, or one ear is noticeably worse than the other. Asymmetric loss warrants medical evaluation before you buy any hearing aid.
4. You have ear pain, drainage, dizziness, or tinnitus that started suddenly. These are red flags for conditions that need medical attention, not amplification.
5. You are looking for an over-the-counter device you can self-fit. Reveal is prescription-only. If you want a self-fitting device, see our OTC vs. prescription comparison and our earbuds guide.
6. Your hearing loss is severe or profound. Confirm that Reveal's fitting range covers your loss. Oticon has not published a fitting-range chart for Reveal as of August 25, 2026. Your audiologist can check the professional datasheet.
7. You want independent clinical data before committing. Reveal is brand new. Manufacturer claims in press materials are not the same as peer-reviewed studies or long-term user satisfaction data. If you prefer proven technology, Intent has more documentation.

If you are unsure whether prescription hearing aids are the right category for your loss, see our guide to 10 early signs of hearing loss for red flags that make a hearing test urgent.

Frequently asked questions